A carregar...
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
Background. Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.Summary. L-ornithine L-aspartate (LOLA) has hepatoprotective properties in patients with fatty liver of diverse etiology and results of...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Russo |
Publicado em: |
Gastro LLC
2019-03-01
|
Colecção: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Assuntos: | |
Acesso em linha: | https://www.gastro-j.ru/jour/article/view/322 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...